Implantable drug-eluting devices (also referred to as implantable drug delivery systems) offer several unique advantages over conventional oral or parenteral drug delivery methods. For instance, they can provide localized, site specific drug delivery,

i which is especially important in applications such as cardiology and oncology, where targeted delivery can improve the effectiveness of treatment and minimize side effects or damage to healthy tissue.ii,

iii The dosage requirements often are lower than alternatives, further reducing the potential for side effects.1 Also, drug-eluting devices can improve patient compliance, one of the greatest challenges in healthcare, as about 50% of conventional medications are not used as prescribed.

iv The treatment regimen can be simpler because it requires fewer doctor’s visits and dosages than traditional therapies.